OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Evotec SE/  DE0005664809  /

Cboe Europe CXE
13/05/2024  15:16:36 Chg. - Volume Bid09:08:48 Ask09:08:34 Market Capitalization Dividend Y. P/E Ratio
9.74EUR - 297
Turnover: 2,894.27		 -Bid Size: - -Ask Size: - 1.69 bill.EUR - -
GlobeNewswire 14/05 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 16/01 HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and ...
GlobeNewswire 11/12/2023 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire 07/11/2023 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire 20/10/2021 Curexsys Appoints Christian Eckert as Chief Operating Officer
GlobeNewswire 11/10/2021 Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement
GlobeNewswire 26/04/2021 Proactive news headlines including Chase Mining Corporation, Red River Resources, Aurumin and Kazia ...
GlobeNewswire 20/04/2021 Proactive news headlines including Queensland Pacific Metals, Moho Resources, Kazia Therapeutics and...
GlobeNewswire 01/03/2021 Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Preci...
GlobeNewswire 20/08/2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
GlobeNewswire 04/06/2020 Toronto Innovation Acceleration Partners Expands its LAB150 Portfolio with a Novel Cancer Therapeut...
GlobeNewswire 12/02/2020 TIAP announces New President and CEO
GlobeNewswire 12/12/2019 Toronto Innovation Acceleration Partners (TIAP) adds novel KRAS oncology project to its LAB150 portf...
GlobeNewswire 11/06/2019 Mental Health is Focus of New High-Potential Anti-Depression Project from MaRS Innovation and the Ce...
GlobeNewswire 07/02/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 07/02/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 15/02/2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire 08/01/2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire 14/09/2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire 29/11/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 10/11/2011 Evotec reports nine months results: Upside materialising
GlobeNewswire 03/11/2011 Evotec to Report Third Quarter Results on 10 November 2011
GlobeNewswire 27/10/2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire 20/10/2011 Evotec and APEIRON Biologics start next project on the Cbl-b target
GlobeNewswire 05/10/2011 Evotec announces second multi-target collaboration with UCB